Delhi/NCR:

Mohali:

Dehradun:

Bathinda:

Mumbai:

Nagpur:

Lucknow:

Bhubaneswar:

To Book an Appointment

Call Us+91 926 888 0303

Radiosurgery for Brain Tumour: Risks, Benefits & Recovery

By Dr Shizan Pervez in Radiation Oncology

Mar 09 , 2026

Radiosurgery for brain tumour is a non-invasive, highly focused radiation treatment used to treat certain brain tumours without making a surgical incision. Despite the name, no scalpel is involved. Instead, precisely targeted radiation beams deliver a high dose of energy to the tumour while minimising exposure to surrounding healthy brain tissue.

 

This approach is commonly used for small tumours, brain metastases, benign brain tumours such as meningioma or acoustic neuroma, and lesions located deep within the brain where open surgery may carry a higher risk. Treatment is typically completed in one session or a few sessions and is often performed as an outpatient procedure. Radiosurgery offers an effective option for selected patients, with shorter recovery time and fewer complications compared to traditional brain surgery.

What Is Stereotactic Radiosurgery?

Stereotactic radiosurgery (SRS) is a specialised form of brain tumour radiation therapy that uses advanced imaging and computer guidance to deliver focused radiation with sub-millimetre precision. It is called “surgery” because:

  • It achieves results similar to surgical removal in selected cases.
  • It precisely targets abnormal tissue.
  • It avoids cutting or opening the skull.

 

Using MRI-guided planning and 3D mapping, neurosurgeons and radiation oncologists define the exact location of the tumour. Focused radiation beams converge at the tumour site, delivering a powerful dose to the target while sparing nearby structures.

Types of Radiosurgery Systems

Several advanced systems are used worldwide. All aim to deliver focused radiation safely.

Gamma Knife Surgery

Gamma Knife surgery uses multiple cobalt radiation sources that converge on a single target point. It is highly accurate and widely used for brain metastases, acoustic neuroma, and small benign tumours.

 

It delivers hundreds of tiny radiation beams that meet at the tumour. Each beam is weak, but together they deliver a powerful treatment dose to the target.

CyberKnife Treatment

CyberKnife treatment uses a robotic arm to deliver radiation from multiple angles. It does not require a rigid head frame and can be more comfortable for some patients. It is particularly useful for:

  • Irregularly shaped tumours
  • Lesions near critical brain structures

Linear Accelerator (LINAC)

LINAC-based systems deliver stereotactic radiation using high-energy X-rays. They are versatile and readily available at major cancer centres.

 

All three methods are non-invasive treatments for brain tumours, and the choice depends on tumour characteristics and institutional expertise.

Who Is a Candidate for Radiosurgery?

Not every brain tumour requires open surgery. Radiosurgery for brain tumour is best suited for:

  • Small brain tumours (usually under 3–4 cm)
  • Brain metastases
  • Acoustic neuroma
  • Meningioma
  • Deep-seated tumours difficult to access surgically
  • Patients medically unfit for open brain surgery
  • Residual tumour after surgery

 

Large tumours causing significant mass effect or increased intracranial pressure may require open surgery instead.

How the Procedure Is Done

Here is a simplified step-by-step overview:

Imaging

High-resolution MRI or CT scans are performed. These images allow accurate tumour targeting.

Treatment Planning

Specialised software maps the tumour in three dimensions. Doctors calculate the optimal radiation dose.

Frame or Mask Placement

  • The Gamma Knife may use a lightweight head frame.
  • CyberKnife or LINAC typically use a custom mask for stabilisation.

Focused Radiation Delivery

Radiation beams are delivered painlessly. Patients remain awake. The session may last 30 minutes to several hours, depending on complexity.

Observation and Discharge

Most treatments are outpatient procedures. After a short observation, patients go home the same day.

Benefits of Radiosurgery for Brain Tumour

Radiosurgery offers several advantages:

  • No incision or skull opening
  • Minimal pain
  • Short recovery time
  • High precision tumour targeting
  • Reduced risk of infection
  • Usually outpatient treatment
  • Minimal interruption of daily life

 

For selected patients, it is an effective alternative to traditional brain surgery.

Risks and Side Effects

Although generally safe, side effects of brain tumour radiation can occur. Common temporary effects include:

  • Headache
  • Fatigue
  • Mild nausea
  • Temporary swelling (oedema) around the tumour

 

Swelling may appear weeks after treatment and is usually managed with medications such as steroids.

 

Rare complications include:

  • Seizures
  • Neurological deficits
  • Radiation necrosis (rare delayed tissue injury)

 

The risk depends on tumour size, location, and dose delivered.

Radiosurgery vs Open Brain Surgery

Patients frequently compare radiosurgery vs open brain surgery.

Invasiveness

  • Radiosurgery: Non-invasive
  • Open surgery: Requires craniotomy and skull opening

Recovery

  • Radiosurgery: Same-day discharge
  • Open surgery: Hospital stay and longer recovery

Suitability

  • Radiosurgery: Small tumours, deep lesions
  • Open surgery: Large tumours, severe pressure symptoms

Limitations

  • Radiosurgery does not physically remove the tumour immediately.
  • Tumour shrinkage may occur gradually over months.

 

Both treatments have important roles in modern neuro-oncology.

Recovery After Radiosurgery

Recovery after stereotactic radiosurgery is usually quick.

  • Most patients resume normal activities within 1–2 days.
  • Mild fatigue may last a few days.
  • Steroids may be prescribed to reduce swelling.

 

Follow-up MRI scans are scheduled at regular intervals to monitor response. Tumour shrinkage is gradual. In some cases, the tumour stops growing rather than disappearing completely. For brain metastases, control rates are high when appropriately selected.

When to Contact Your Doctor After Treatment

Seek medical attention if you experience:

  • Severe or worsening headache
  • New weakness or numbness
  • Vision problems
  • Persistent vomiting
  • Seizures
  • Changes in consciousness

Conclusion

Radiosurgery for brain tumour represents one of the most significant advances in modern neurosurgery and radiation oncology. By delivering focused radiation with extreme precision, it provides an effective, non-invasive treatment option for selected patients with brain tumours.

 

It is not suitable for every tumour. However, for small lesions, brain metastases, and deep-seated tumours, stereotactic radiosurgery offers excellent tumour control with shorter recovery and fewer complications compared to open surgery.

 

A multidisciplinary evaluation by a neurosurgeon and radiation oncologist ensures the best personalised treatment plan.

Frequently Asked Questions

Does radiosurgery completely remove the tumour?

Radiosurgery does not physically remove the tumour. Instead, it damages tumour cells, causing them to stop growing or shrink over time. Some tumours become inactive and stable rather than disappearing completely.

 

How long does the procedure take?

Treatment duration varies. Planning may take a few hours, while radiation delivery typically lasts 30 minutes to 2 hours. Most patients go home the same day.

 

Can radiosurgery be repeated?

Yes, in selected cases. If new brain metastases develop or if residual tumour persists, radiosurgery may be repeated depending on prior dose and overall health.

 

Is hair loss common after radiosurgery?

Hair loss is uncommon because radiation is highly focused. If it occurs, it is usually limited to a small patch near the treatment site and often temporary.

 

Is radiosurgery safe for elderly patients?

Yes, because it is non-invasive and avoids general anaesthesia, it is often well tolerated by older adults who may not be ideal candidates for open surgery.

 

Can children undergo radiosurgery?

In carefully selected cases, yes. Pediatric neuro-oncology teams evaluate risks and long-term considerations before recommending treatment.